Skip to main content
. 2014 Mar 15;7(4):1695–1701.

Figure 2.

Figure 2

Representative immunostaining of SKIP in high-grade urothelial carcinoma samples (A, B), and low-grade urothelial carcinoma samples (C, D). High expression of SKIP (A, B) is showed in high-grade urothelial carcinoma samples and low expression of SKIP (C, D) is showed in low-grade urothelial carcinoma samples.